Lybrido(s) and SSRIs @Home: A double blind, randomized, cross-over placebo controlled study to investigate the subjective and physiological efficacy and safety of Lybrido and Lybridos in the domestic setting in healthy female subjects with Female Sexual Dysfunction in combination with SSRI use.
Phase of Trial: Phase II
Latest Information Update: 07 Nov 2011
At a glance
- Drugs Buspirone/testosterone (Primary) ; Sildenafil/testosterone (Primary)
- Indications Female sexual dysfunction
- Focus Therapeutic Use
- Acronyms @HOME; AT-HOME
- Sponsors Emotional Brain
- 13 May 2011 Planned end date changed from 1 Jan 2011 to 1 Jan 2012 as reported by Netherlands Trial Register.
- 29 Jan 2010 New trial record